about
Azathioprine induced nodular regenerative hyperplasia in IBD patients.Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinomaTransient elastography: a new noninvasive method for assessment of hepatic fibrosis.Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.Routine surgical pathology in general surgery.Renal granulomatoses: a retrospective study of 40 cases and review of the literature.Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.Hepatic endometrioma: a case report and review of the literature: report of a case.Q fever and Mediterranean spotted fever associated with hemophagocytic syndrome: case study and literature review.GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells.[Extramedullary blastic transformation revealed by a prolonged fever during the course of a 5q- syndrome].Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology.Hemophagocytic Lymphohistiocytosis Associated With Bartonella henselae Infection in an HIV-Infected Patient.Keratin 23 is a stress-inducible marker of mouse and human ductular reaction in liver disease.HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis.[Reactivation of viral hepatitis C during autoimmune hepatitis treated by immunosuppressive agents].Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.Telomerase gene mutations are associated with cirrhosis formation.Virological and biological characteristics of cervical intraepithelial neoplasia grade I with marked koilocytotic atypia.Amino acid modifications in the wild type sequence p53 232-240 overcome the poor immunogenicity of this self tumour epitope.Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.Intermediate hepatobiliary cells predict an increased risk of hepatocarcinogenesis in patients with hepatitis C virus-related cirrhosis.Expression of Granzyme B in viral hepatitis in patients with ALPS.Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.Manganese superoxide dismutase dimorphism and iron overload, hepatocellular carcinoma, and death in hepatitis C virus-infected patients.Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients.Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death.Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis.A "self adhering" prosthesis for hernia repair: experimental study.ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.Synergistic deleterious effect of hypoxemia and hypovolemia on microcirculation in intestinal villi*.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.
P50
Q33217982-249B83EA-E24F-4E83-BF3B-2F88886275EFQ34451128-48E635EB-D135-40BF-AC95-881C45710DCDQ34544284-04A971A1-7A83-40E1-A323-AA8C6FB85A24Q34585594-5DF0CF54-BA61-49D7-9103-B123387B1B93Q36393049-818A7190-0447-4860-A7CC-C94278744D1AQ36823487-6A1B3A3D-7363-4CC3-9260-CDB3C73A7596Q37697013-9EA09630-CA31-482B-88C9-AC3C05941710Q38053380-D1F01780-B483-4312-9F28-973BDDE736CBQ38080964-DB2B1811-9E54-4495-A04F-6A8DDEC41660Q38307916-37FC445D-82BC-4E8B-8B16-3A7A43D9E409Q38714435-96522ADB-0093-48D0-8D8D-07894F59FE4CQ39376677-AB7FB57F-EFC7-4FED-B285-495BCCE34B77Q39945111-B055FFC3-94D2-482A-87F7-2743C6015C19Q40380215-8E137B23-4DAE-4322-BA1D-F15BBEC1FC6BQ40467529-35ADEC73-9CA0-4E61-A00A-247DBCED8E60Q40491093-5BAD4EBB-12DD-4A70-82EC-2BE17A8CB10FQ40833423-E46AFFDE-CC42-448F-833B-0AC0FFF8DA47Q40879085-D2B21A30-1D5C-4CC5-BB41-21652C739A4BQ42492814-0BAFE07E-713E-43D5-B995-DF363FD4720FQ43040452-8A6C5BBB-8076-4143-B2E3-B327A6A532F4Q43047873-7A0F3C8E-85CC-449F-85EB-63EDA742B3C2Q43147462-732EA179-3629-4C0B-B55C-8B874C9BEAACQ43280918-646B8EFA-3360-49E0-A1C7-1458E678282CQ43444556-31DEDD74-B292-4CAB-8AC6-AED915535DCFQ43652822-19091711-D15C-4993-8156-2BC8C934849AQ44083202-582AA187-A4DE-4BA5-A913-327420911E4DQ44391171-97971970-68E7-470B-BF1F-5E9626B6E5F2Q44410161-FDE6C8D9-29F1-49CB-93A7-3592FFF1A142Q44785889-1DE406F3-6FD2-4709-B690-68DEA9CBD5B2Q45392148-5A4E2FF9-E69D-4177-92E7-959A249A2DD8Q45406568-E010B615-716D-4ECA-842B-5A7BA622BA04Q45421063-6E2B52D1-A94E-48B9-A214-38CD6F479D94Q46376179-D3870407-837B-4FB1-AB09-86A919047C0DQ46970895-F2CE2727-573F-430B-81F2-2FB765BD3C67Q47381846-400130DE-72E3-4D5D-8309-40CAD16010B7Q47825139-1F18090F-9A2B-43B0-85BD-04DFAC16C196Q47849653-92BE6CC1-3882-41DD-857F-D8F220032190Q50335628-EA5C00D9-941B-440C-BFE5-2E937E364012Q50780985-D7AEE3C6-498B-479B-A66A-3B19459C52C1Q51545030-3D992647-7149-45CF-B6C7-961B8E85AAFE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marianne Ziol
@ast
Marianne Ziol
@en
Marianne Ziol
@es
Marianne Ziol
@nl
Marianne Ziol
@sl
type
label
Marianne Ziol
@ast
Marianne Ziol
@en
Marianne Ziol
@es
Marianne Ziol
@nl
Marianne Ziol
@sl
prefLabel
Marianne Ziol
@ast
Marianne Ziol
@en
Marianne Ziol
@es
Marianne Ziol
@nl
Marianne Ziol
@sl
P106
P1153
7003270066
P21
P31
P496
0000-0001-5117-4842